Advanced search
Publication Cover
Leukemia & Lymphoma Volume 40, 2000 - Issue 1-2
Submit an article Journal homepage
38
Views
5
CrossRef citations to date
0
Altmetric
Original Article

Experience with 9-Cis Retinoic Acid in Patients with Relapsed and Refractory Non-Hodgkin's Lymphoma

Anas Younes Department Of Lymphoma and Myeloma, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USACorrespondenceayounesr`@mdanderson.org
,
Massimo Cristofanilli Department Of Lymphoma and Myeloma, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA
,
Peter McLaughlin Department Of Lymphoma and Myeloma, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA
,
Frederick B. Hagemeister Department Of Lymphoma and Myeloma, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA
,
Donna Weber Department Of Lymphoma and Myeloma, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA
,
Ofelia Mesina Department Of Lymphoma and Myeloma, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA
&
Fernando Cabanillas Department Of Lymphoma and Myeloma, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA
 show all
Pages 79-85 | Received 20 Apr 2000, Published online: 01 Jul 2009

References

  • Lotan R. Retinoids and their receptors in modulation of differentiation, development, and prevention of head and neck cancers. Anticancer Res 1996; 16: 2415–2419
  • Muindi J. R. Retinoids in clinical cancer therapy. Cancer Treat Res 1996; 87: 305–342
  • Kurie J. M., Lee J. S., Griffin T., Lippman S. ML, Drum P., Thomas M. P., Weber C., Bader M., Massimini G., Hong W. K. Phase I trial of 9-cis retinoic acid in adults with solid tumors. Clin Cancer Res 1996; 2: 287–293
  • Miller W. H., Jr., Jakubowski A., Tong W. P., Miller V. A., Rigas J. R., Benedetti F., Gill G. M., Truglia J. A., Ulm E., Shirley M., Warrell R. P. 9-cis retinoic acid induces complete remission but does not reverse clinically acquired retinoid resistance in acute promyelocytic leukemia. Blood 1995; 85: 3021–3027
  • Warrell R. P., Jr., De The H., Wang Z. Y., Degos L. Acute promyelocytic leukemia. N Engl J Med 1993; 329: 177–189
  • Fenaux P., Chomienne C. Biology and treatment of acute promyelocytic leukemia. Curr Opin Oncol 1996; 8: 3–12
  • Tallman M. S., Andersen J. W., Schiffer C. A., Appelbaum F. R., Feusner J. H., Ogden A., Shepherd L., Willman C., Bloomfield C. D., Rowe J. M., Wiernik P. H. All-trans-retinoic acid in acute promyelocytic leukemia. N Engl J Med 1997; 337: 1021–1028
  • Kessler J. F., Meyskens F. L., Levine N., Lynch P. J., Jones S. E. Treatment of cutaneous T-cell lymphoma (mycosis fungoides) with 13-cis-retinoic acid. Lancet 1983; 1: 1345–1347
  • Cheng A. L., Su I. J., Chen C. C., Tien H. F., Lay J. D., Chen B. R., Pu Y. S., Hong R. L., Shen M. C., Wang C. H. Use of retinoic acids in the treatment of peripheral T-cell lymphoma: a pilot study. J Clin Oncol 1994; 12: 1185–1192
  • Harris N. L., Jaffe E. S., Stein H., Banks P. M., Chan J. K., Cleary M. L., Delsol G., De Wolf-Peeters C., Falini B., Gatter K. C. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361–1392
  • Miller V. A., Rigas J. R., Benedetti F. M., Verret A. L., Tong W. P., Kris M. G., Gill G. M., Loewen G. R., Truglia J. A., Ulm E. H., Warrell R. P. Initial clinical trial of the retinoid receptor pan agonist 9-cis retinoic acid. Clin Cancer Res 1996; 2: 471–475
  • Delia D., Aiello A., Formelli F., Fontanella E., Costa A., Miyashita T., Reed J. C., Pierotti M. A. Regulation of apoptosis induced by the retinoid N-(4-hydroxyphe-nyl) retinamide and effect of deregulated bcl-2. Blood 1995; 85: 359–67
  • Shalinsky D. R., Bischoff E. D., Gregory M. L., Lamph W. W., Heyman R. A., Hayes J. S., Thomazy V., Davies P. J. Enhanced antitumor efficacy of cisplatin in combination with ALRT1057 (9-cis retinoic acid) in human oral squamous carcinoma xenografts in nude mice. Clin Cancer Res 1996; 2: 511–520

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.